Goldman Sachs says this little-known health stock can withstand volatile macro environment, rise more than 35%
This health testing name may be insulated from President Donald Trump's tariff uncertainty, according to Goldman Sachs.
GDP contracted by 0.3% q.q saar in 1Q, despite solid final demand (+2.3%). In our assessment, the surge in imports (which took 5.0pp off 1Q growth) due to front-r…